Skip to main content
Fachgebiete
Automobil + Motoren Bauwesen + Immobilien Business IT + Informatik Elektrotechnik + Elektronik Energie + Nachhaltigkeit Finance + Banking Management + Führung Marketing + Vertrieb Maschinenbau + Werkstoffe Versicherung + Risiko
DE
EN
Bücher
Zeitschriften
Themenseiten
Organisationspsychologie Projektmanagement Marketing Smart Manufacturing
Weitere Formate
Podcasts Webinare Technik Webinare Wirtschaft Kongresse Veranstaltungskalender Awards
Jetzt Einzelzugang starten
Zugang für Unternehmen
Referenzkunden
SLX-Digitalkonferenz: Zukunftswerkstatt 2024

Mehr Umsatz mit Top-Kontakten

Am 7. Mai erfahren Sie, wie Vertriebsteams Leadgenerierung, Leadnurturing und Leadstrategien effizient steuern können.
Erweiterte Suche
Anmelden
nach oben
Journal of Nanoparticle Research
Erschienen in: Journal of Nanoparticle Research 9/2022

01.09.2022 | Review

Nanoparticle application in diabetes drug delivery

verfasst von: Seyedeh Sabereh Samavati, Soheila Kashanian, Hossein Derakhshankhah, Morteza Rabiei

Erschienen in: Journal of Nanoparticle Research | Ausgabe 9/2022

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

The management of diabetes, in contrast to the treatment of the disease, is basically aimed at controlling the blood glucose level. Besides the primary changes required in the lifestyle and diet of the patient, drug therapy can play a critical role in the diabetes management. Diabetic drugs are formulated in various forms to permit oral, transdermal, internasal, or delivery by subcutaneous injection. Notably, in formulations intended for controlled release, targeted delivery, and those requiring protection of the therapeutic agent, nanoparticles (NPs) play a crucial role. Nanoparticle-based drug formulations can also alleviate the common side effects associated with the regular administration of pure drugs. In this review, we will consider the impact of NPs on the delivery of both oral and injectable drugs to manage diabetes as well as the potential application of nanotechnology to the development of devices such as microneedles aimed at improving the delivery of diabetes drugs.
Vorheriger Artikel Rational design of fluorinated graphene-porphyrin nanoarchitectonics: integrating hydrophobicity to macromolecular heterocyclic systems
Nächster Artikel Graphene-based polymer nanocomposites in food packaging and factors affecting the behaviour of graphene-based materials: a review

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Jetzt informieren
Literatur
1.
Hu M, Cherkaoui I, Misra S, Rutter GA (2020) Functional genomics in pancreatic β cells: recent advances in gene deletion and genome editing technologies for diabetes research. Front Endocrinol 11
2.
Veiseh O, Tang BC, Whitehead KA, Anderson DG, Langer R (2015) Managing diabetes with nanomedicine: challenges and opportunities. Nat Rev Drug Discovery 14:45CrossRef
3.
Hussain T, Tan B, Murtaza G, Liu G, Rahu N, Kalhoro MS, Kalhoro DH, Adebowale TO, Mazhar MU, urRehman Z (2020) Flavonoids and type 2 diabetes: evidence of efficacy in clinical and animal studies and delivery strategies to enhance their therapeutic efficacy. Pharmacol Res 152:104629CrossRef
4.
Sarmah S, Pahari S, Belwal VK, Jana M, Roy AS (2020) Elucidation of molecular interaction of bioactive flavonoid luteolin with human serum albumin and its glycated analogue using multi-spectroscopic and computational studies. J Mol Liq 318:114147CrossRef
5.
Qiu H, Jin L, Chen J, Shi M, Shi F, Wang M, Li D, Xu X, Su X, Yin X (2020) Comprehensive glycomic analysis reveals that human serum albumin glycation specifically affects the pharmacokinetics and efficacy of different anticoagulant drugs in diabetes. Diabetes 69:760–770CrossRef
6.
Hörber S, Achenbach P, Schleicher E, Peter A (2020) Harmonization of immunoassays for biomarkers in diabetes mellitus. Biotechnol Adv 39:107359CrossRef
7.
Zhang Y, Li J, Wu M, Guo Z, Tan D, Zhou X, Li Y, Liu S, Xue L, Lei Y, (2020) Glucose-responsive gold nanocluster-loaded microneedle patch for type 1 diabetes therapy. ACS Appl Bio Mater
8.
Dovc K, Battelino T (2020) Closed-loop insulin delivery systems in children and adolescents with type 1 diabetes. Expert Opin Drug Deliv 17:157–166CrossRef
9.
Zamboni F, Collins MN (2017) Cell based therapeutics in type 1 diabetes mellitus. Int J Pharm 521:346–356CrossRef
10.
Yamada Y, Tabata M, Yasuzaki Y, Nomura M, Shibata A, Ibayashi Y, Taniguchi Y, Sasaki S, Harashima H (2014) A nanocarrier system for the delivery of nucleic acids targeted to a pancreatic beta cell line. Biomaterials 35:6430–6438CrossRef
11.
Wu M, Liao L, Jiang L, Zhang C, Gao H, Qiao L, Liu S, Shi D (2019) Liver-targeted nano-MitoPBN normalizes glucose metabolism by improving mitochondrial redox balance. Biomaterials 222:119457CrossRef
12.
Kazemi F, Divsalar A, Saboury AA, Seyedarabi A (2019) Propolis nanoparticles prevent structural changes in human hemoglobin during glycation and fructation. Colloids Surf, B 177:188–195CrossRef
13.
Lakkireddy HR, Urmann M, Besenius M, Werner U, Haack T, Brun P, Alié J, Illel B, Hortala L, Vogel R (2016) Oral delivery of diabetes peptides—comparing standard formulations incorporating functional excipients and nanotechnologies in the translational context. Adv Drug Deliv Rev 106:196–222CrossRef
14.
Sharma G, Sharma AR, Nam J-S, Doss GPC, Lee S-S, Chakraborty C (2015) Nanoparticle based insulin delivery system: the next generation efficient therapy for type 1 diabetes. J Nanobiotechnol 13:74CrossRef
15.
Sharma R, Gupta U, Garg NK, Tyagi RK, Jain N (2015) Surface engineered and ligand anchored nanobioconjugate: an effective therapeutic approach for oral insulin delivery in experimental diabetic rats. Colloids Surf, B 127:172–181CrossRef
16.
Jayakrishnapillai P, Nair SV, Kamalasanan K (2017) Current trend in drug delivery considerations for subcutaneous insulin depots to treat diabetes. Colloids Surf, B 153:123–131CrossRef
17.
Dungan K, DeSantis A, (2016) Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes mellitus, Up to date Nov, 21
18.
Chen Y, Li Y, Shen W, Li K, Yu L, Chen Q, Ding J (2016) Controlled release of liraglutide using thermogelling polymers in treatment of diabetes. Sci Rep 6:31593CrossRef
19.
Tahrani AA, Barnett AH, Bailey CJ (2016) Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus. Nat Rev Endocrinol 12:566CrossRef
20.
Li L, Jiang G, Yu W, Liu D, Chen H, Liu Y, Tong Z, Kong X, Yao J (2017) Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin. Mater Sci Eng, C 70:278–286CrossRef
21.
Shamsi A, Ahmed A, Khan MS, Husain FM, Bano B, (2020) Rosmarinic acid restrains protein glycation and aggregation in human serum albumin: multi spectroscopic and microscopic insight-possible therapeutics targeting diseases. Int J Biol Macromol
22.
AlBab ND, Hameed MK, Maresova A, Ahmady IM, Arooj M, Han C, Workie B, Chehimi M, Mohamed AA (2020) Inhibition of amyloid fibrillation, enzymatic degradation and cytotoxicity of insulin at carboxyl tailored gold-aryl nanoparticles surface. Colloids Surf, A 586:124279CrossRef
23.
Shilo M, Berenstein P, Dreifuss T, Nash Y, Goldsmith G, Kazimirsky G, Motiei M, Frenkel D, Brodie C, Popovtzer R (2015) Insulin-coated gold nanoparticles as a new concept for personalized and adjustable glucose regulation. Nanoscale 7:20489–20496CrossRef
24.
Wu S, Bin W, Tu B, Li X, Wang W, Liao S, Sun C (2019) A delivery system for oral administration of proteins/peptides through bile acid transport channels. J Pharm Sci 108:2143–2152CrossRef
25.
Wu L, Bai Y, Wang L, Liu X, Zhou R, Li L, Wu R, Zhang Z, Zhu X, Huang Y (2020) Promoting apical-to-basolateral unidirectional transport of nanoformulations by manipulating the nutrient-absorption pathway. J Control Release
26.
Chen Y, Shan X, Luo C, He Z (2020) Emerging nanoparticulate drug delivery systems of metformin. J Pharm Investig 1–12
27.
Baig MMFA, Abbas M, Naveed M, Kassim SA, Khan GJ, Sohail M, Ullah S, Hasnat M, Shah K, Ansari MT (2019) Design, synthesis and evaluation of DNA nano-cubes as a core material protected by the alginate coating for oral administration of anti-diabetic drug. J Food Drug Anal 27:805–814CrossRef
28.
Fang X, Yang T, Wang L, Yu J, Wei X, Zhou Y, Wang C, Liang W (2016) Nano-cage-mediated refolding of insulin by PEG-PE micelle. Biomaterials 77:139–148CrossRef
29.
Zhang Y, Li J, Wang Z, Xu M-Z, Zeng Z, Huang J-P, Guan Y-Q (2020) Natural plant-derived polygalacturonic acid-oleanolic acid assemblies as oral-delivered nanomedicine for insulin resistance treatment. Chem Eng J 124630.
30.
Hu X, Yu J, Qian C, Lu Y, Kahkoska AR, Xie Z, Jing X, Buse JB, Gu Z (2017) H2O2-responsive vesicles integrated with transcutaneous patches for glucose-mediated insulin delivery. ACS Nano 11:613–620CrossRef
31.
Yu J, Zhang Y, Yan J, Kahkoska AR, Gu Z (2018) Advances in bioresponsive closed-loop drug delivery systems. Int J Pharm 544:350–357CrossRef
32.
Mohammadpour F, Hadizadeh F, Tafaghodi M, Sadri K, Mohammadpour AH, Kalani MR, Gholami L, Mahmoudi A, Chamani J (2019) Preparation, in vitro and in vivo evaluation of PLGA/chitosan based nano-complex as a novel insulin delivery formulation. Int J Pharm 572:118710CrossRef
33.
Sharma D, Arora S, Singh J (2019) Smart thermosensitive copolymer incorporating chitosan–zinc–insulin electrostatic complexes for controlled delivery of insulin: effect of chitosan chain length. Int J Polym Mater PolymBiomater 1–15
34.
Seo B-B, Park M-R, Song S-C (2019) Sustained release of exendin 4 using injectable and ionic-nano-complex forming polymer hydrogel system for long-term treatment of type 2 diabetes mellitus. ACS Appl Mater Interfaces 11:15201–15211CrossRef
35.
Gilroy CA, Luginbuhl KM, Chilkoti A (2016) Controlled release of biologics for the treatment of type 2 diabetes. J Control Release 240:151–164CrossRef
36.
Schwenk RW, Baumeier C, Finan B, Kluth O, Brauer C, Joost H-G, DiMarchi RD, Tschöp MH, Schürmann A (2015) GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice. Diabetologia 58:604–614CrossRef
37.
Saatchi K, Tod SE, Leung D, Nicholson KE, Andreu I, Buchwalder C, Schmitt V, Häfeli UO, Gray SL (2017) Characterization of alendronic-and undecylenic acid coated magnetic nanoparticles for the targeted delivery of rosiglitazone to subcutaneous adipose tissue, Nanomedicine: Nanotechnology. Bio Med 13:559–568
38.
Xu B, Jiang G, Yu W, Liu D, Liu Y, Kong X, Yao J (2017) Preparation of poly (lactic-co-glycolic acid) and chitosan composite nanocarriers via electrostatic self assembly for oral delivery of insulin. Mater Sci Eng, C 78:420–428CrossRef
39.
Omid NJ, Javan NB, Dehpour A-R, Partoazar A, Tehrani MR, Dorkoosh F (2018) In-vitro and in-vivo cytotoxicity and efficacy evaluation of novel glycyl-glycine and alanyl-alanine conjugates of chitosan and trimethyl chitosan nano-particles as carriers for oral insulin delivery. Int J Pharm 535:293–307CrossRef
40.
Zhang Y, Zhang L, Ban Q, Li J, Li C-H, Guan Y-Q (2018) Preparation and characterization of hydroxyapatite nanoparticles carrying insulin and gallic acid for insulin oral delivery, Nanomedicine: Nanotechnology. Biol Med 14:353–364
41.
Kozuka C, Shimizu-Okabe C, Takayama C, Nakano K, Morinaga H, Kinjo A, Fukuda K, Kamei A, Yasuoka A, Kondo T (2017) Marked augmentation of PLGA nanoparticle-induced metabolically beneficial impact of γ-oryzanol on fuel dyshomeostasis in genetically obese-diabetic ob/ob mice. Drug Deliv 24:558–568CrossRef
42.
Fullagar B, Rao W, Gilor C, Xu F, He X, Adin CA (2017) Nano-encapsulation of bilirubin in pluronic F127–chitosan improves uptake in β cells and increases islet viability and function after hypoxic Stress. Cell Transpl 26:1703–1715CrossRef
43.
Maiti S, Mukherjee S, Datta R (2014) Core–shell nano-biomaterials for controlled oral delivery and pharmacodynamic activity of glibenclamide. Int J Biol Macromol 70:20–25CrossRef
44.
Baig MMFA, Khan S, Naeem MA, Khan GJ, Ansari MT (2018) Vildagliptin loaded triangular DNA nanospheres coated with eudragit for oral delivery and better glycemic control in type 2 diabetes mellitus. Biomed Pharmacother 97:1250–1258CrossRef
45.
Varanko AK, Chilkoti A (2019) Molecular and materials engineering for delivery of peptide drugs to treat type 2 diabetes. Adv Healthcare Mater 8:1801509CrossRef
46.
Cho EY, Ryu J-Y, Lee HAR, Hong SH, Park HS, Hong KS, Park S-G, Kim HP, Yoon T-J (2019) Lecithin nano-liposomal particle as a CRISPR/Cas9 complex delivery system for treating type 2 diabetes. J Nanobiotech 17:19CrossRef
47.
Rabiei M, Kashanian S, Samavati SS, Jamasb S, McInnes SJ (2019) Nanomaterial and advanced technologies in transdermal drug delivery. J Drug Target 1–12
48.
Ye Y, Yu J, Wen D, Kahkoska AR, Gu Z (2018) Polymeric microneedles for transdermal protein delivery. Adv Drug Deliv Rev 127:106–118CrossRef
49.
Yu J, Wang J, Zhang Y, Chen G, Mao W, Ye Y, Kahkoska AR, Buse JB, Langer R, Gu Z, (2020) Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs. Nat Biomed Eng 1–8
50.
Rabiei M, Kashanian S, Bahrami G, Derakhshankhah H, Barzegari E, Samavati SS, McInnes SJ (2021) Dissolving microneedle-assisted long-acting liraglutide delivery to control type 2 diabetes and obesity. Eur J Pharm Sci 167:106040CrossRef
51.
Chen G, Yu J, Gu Z (2019) Glucose-responsive microneedle patches for diabetes treatment. J Diabetes Sci Technol 13:41–48CrossRef
52.
Zhang Y, Wang J, Yu J, Wen D, Kahkoska AR, Lu Y, Zhang X, Buse JB, Gu Z (2018) Bioresponsive microneedles with a sheath structure for H2O2 and pH cascade-triggered insulin delivery. Small 14:1704181CrossRef
53.
Tong Z, Zhou J, Zhong J, Tang Q, Lei Z, Luo H, Ma P, Liu X (2018) Glucose-and H2O2-responsive polymeric vesicles integrated with microneedle patches for glucose-sensitive transcutaneous delivery of insulin in diabetic rats. ACS Appl Mater Interfaces 10:20014–20024CrossRef
54.
Yu J, Qian C, Zhang Y, Cui Z, Zhu Y, Shen Q, Ligler FS, Buse JB, Gu Z (2017) Hypoxia and H2O2 dual-sensitive vesicles for enhanced glucose-responsive insulin delivery. Nano Lett 17:733–739CrossRef
55.
Wang J, Ye Y, Yu J, Kahkoska AR, Zhang X, Wang C, Sun W, Corder RD, Chen Z, Khan SA (2018) Core–shell microneedle gel for self-regulated insulin delivery. ACS Nano 12:2466–2473CrossRef
56.
Xu B, Jiang G, Yu W, Liu D, Zhang Y, Zhou J, Sun S, Liu Y (2017) H 2 O 2-responsive mesoporous silica nanoparticles integrated with microneedle patches for the glucose-monitored transdermal delivery of insulin. J Mater Chem B 5:8200–8208CrossRef
57.
Fu Y, Liu P, Chen M, Jin T, Wu H, Hei M, Wang C, Xu Y, Qian X, Zhu W (2022) On-demand transdermal insulin delivery system for type 1 diabetes therapy with no hypoglycemia risks. J Colloid Interface Sci 605:582–591CrossRef
58.
Chen W, Tian R, Xu C, Yung BC, Wang G, Liu Y, Ni Q, Zhang F, Zhou Z, Wang J (2017) Microneedle-array patches loaded with dual mineralized protein/peptide particles for type 2 diabetes therapy. Nat Commun 8:1–11CrossRef
59.
Hu W, Su Y-W, Jiang Y-K, Fan W-D, Cheng S-Y, Tong Z-Z, Cen C, Jiang G-H (2022) Polymer vesicles with upper critical solution temperature for near-infrared light-triggered transdermal delivery of metformin in diabetic rats. Chin J Polym Sci 40:157–165CrossRef
60.
Tsou YH, Wang B, Ho W, Hu B, Tang P, Sweet S, Zhang XQ, Xu X (2019) Nanotechnology-mediated drug delivery for the treatment of obesity and its related comorbidities. Adv Healthcare Mater 8:1801184CrossRef
61.
Zhang Y, Liu Q, Yu J, Yu S, Wang J, Qiang L, Gu Z (2017) Locally induced adipose tissue browning by microneedle patch for obesity treatment. ACS Nano 11:9223–9230CrossRef
62.
trial NCT 02827094 (i.e. enhanced epidermal antigen specific immunotherapy trial -1 EE-ASI-1
63.
Dul M, Nikolic T, Stefanidou M, McAteer M, Williams P, Mous J, Roep B, Kochba E, Levin Y, Peakman M (2019) Conjugation of a peptide autoantigen to gold nanoparticles for intradermally administered antigen specific immunotherapy. Int J Pharm 562:303–312CrossRef
Metadaten
Titel
Nanoparticle application in diabetes drug delivery
verfasst von
Seyedeh Sabereh Samavati
Soheila Kashanian
Hossein Derakhshankhah
Morteza Rabiei
Publikationsdatum
01.09.2022
Verlag
Springer Netherlands
Erschienen in
Journal of Nanoparticle Research / Ausgabe 9/2022
Print ISSN: 1388-0764
Elektronische ISSN: 1572-896X
DOI
https://doi.org/10.1007/s11051-022-05547-8

Weitere Artikel der Ausgabe 9/2022

Journal of Nanoparticle Research 9/2022 Zur Ausgabe

Research paper

Rational design of fluorinated graphene-porphyrin nanoarchitectonics: integrating hydrophobicity to macromolecular heterocyclic systems

Research paper

Simulation study on the effect of pore structure and surface curvature of activated carbon on the adsorption and separation performance of CO2/N2

Research paper

Academic nanotechnology laboratories: investigating good practices and students’ health status

Research paper

Effective gene delivery based on facilely synthesized “core–shell” Ag@PDA@PEI nanoparticles

Research paper

Morin-loaded nanoceria as an efficient nanoformulation for increased antioxidant and antibacterial efficacy

Review

Graphene-based polymer nanocomposites in food packaging and factors affecting the behaviour of graphene-based materials: a review

Premium Partner

    Marktübersichten

    Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen. 

    Zur Marktübersicht
    Bildnachweise